Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database.
Chris J KapeliosLars H LundOmar Wever-PinzonCraig H SelzmanSusan L MyersRyan S CantorJosef StehlikThemistocles ChamogeorgakisStephen H McKellarAntigone KoliopoulouRami AlharethiAbdallah G KfouryMichael BoniosStamatis AdamopoulosEdward M GilbertJames C FangJames K KirklinStavros G DrakosPublished in: Circulation. Heart failure (2022)
RHF at 1 or 3 months post-LVAD was a common and frequently transient condition, which, if resolved, was associated with relatively favorable prognosis. Conversely, de novo, late RHF post-LVAD (>6 months) was more frequently a persistent disorder and associated with increased mortality. The 1-, 3-, and 6-month time points may be used for RHF assessment and risk stratification in LVAD recipients.
Keyphrases
- heart failure
- risk factors
- left ventricular
- left ventricular assist device
- cardiac resynchronization therapy
- cardiovascular events
- hypertrophic cardiomyopathy
- acute myocardial infarction
- adipose tissue
- cardiovascular disease
- mitral valve
- emergency department
- coronary artery disease
- cerebral ischemia
- acute heart failure
- skeletal muscle
- subarachnoid hemorrhage
- aortic valve
- glycemic control